Biotech Investors Gamble On Ebola Stocks
October 07, 2014 at 06:39 AM EDT
The recent outbreaks of Ebola in Africa and the first case found in the U.S. have also heightened the FDA’s awareness of disease outbreaks and the need for stronger safety measures, but nothing gets investors salivating more that and constant media attention.